NCIDCTD230001 Amend 0001.pdf

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

(a) By completing items 8 and 15, and returning or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE

RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

E. IMPORTANT: Contractor is not is required to sign this document and return copies to the issuing office.

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

1. CONTRACT ID CODE

2. AMENDMENT/MODIFICATION NUMBER 3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQUISITION NUMBER 5. PROJECT NUMBER (If applicable)

7. ADMINISTERED BY (If other than Item 6) CODE

STANDARD FORM 30 (REV. 11/2016)

Prescribed by GSA FAR (48 CFR) 53.243

FACILITY CODE

9A. AMENDMENT OF SOLICITATION NUMBER

9B. DATED (SEE ITEM 11)

10A. MODIFICATION OF CONTRACT/ORDER NUMBER

10B. DATED (SEE ITEM 13)

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended. is not extended.

12. ACCOUNTING AND APPROPRIATION DATA (If required) copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.

IT MODIFIES THE CONTRACT/ORDER NUMBER AS DESCRIBED IN ITEM 14.

CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER

NUMBER IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority)

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15C. DATE SIGNED

15A. NAME AND TITLE OF SIGNER (Type or print)

16C. DATE SIGNED

16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

PAGE OF PAGES

6. ISSUED BY CODE

8. NAME AND ADDRESS OF CONTRACTOR (Number, street, county, State and ZIP Code) (X)

CODE

15B. CONTRACTOR/OFFEROR

(Signature of person authorized to sign)

16B. UNITED STATES OF AMERICA

(Signature of Contracting Officer)

Previous edition unusable

Christy L. Hunter

Purpose: To make a correction to the Mandatory Qualification Criteria for Facility Mandatory Qualification, in the enclosed attachment.

National Institutes of Health National Cancer Institute Frederick, MD 21701

TO ALL CONTRACTORS

NCI-DCTD-23-0001

1 4

04/26/2022

4/26/2022

Pre-solicitation Notice: RFP No. NCI-DCTD-23-0001 Amendment 0001

Changes are in BOLD below:

Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development

Contracting Office Address

Department of Health and Human Services, National Institutes of Health (NIH), National Cancer Institute (NCI), Office of Acquisitions (OA), Riverside Five, 8490 Progress Drive, Suite 400, Frederick, MD 21701-4998.

Note: This synopsis follows Small Business Sources Sought (SBSS) notice that was released on October 06, 2021, under NCI-DCTD-23-0001.

Description

The Drug Synthesis and Chemistry Branch (DSCB) of the Developmental Therapeutics Program (DTP) of the Division of Cancer Treatment and Diagnosis (DCTD) of the National Cancer Institute (NCI) is seeking support services to operate and maintain the National Cancer Institute’s Chemotherapeutic Agents Repository (NCI-CAR). This acquisition is responsible for providing an informational interface with NCI and external investigators that are submitting or requesting research compounds; for updating of the chemical database which includes chemical, inventory, receiving and shipping information; systematic file and record keeping of both current and archival information related to repository activities; and reacquisition of samples for continued chemical and biological studies. Towards this goal, the Program acquires and evaluates about 5,000 single agents each year in anticancer assays. In addition, research samples are provided to the general research community both in vialed and plated format. NCI-CAR is responsible for receiving, storage and distribution services along with curating an inventory of approximately 500,000 - 600,000 individual samples and associated chemical, inventory and distribution data. Approximately 400 samples are received monthly, registered, and shipped to NCI testing facilities; an additional 2,500 samples are weighed monthly from inventory and shipped to research investigators both in the U.S. (including NCI) and foreign countries.

This acquisition will be to establish (1) one Indefinite Delivery-Indefinite Quantity (IDIQ) contract, as described in the Attached Draft Statement of Works (SOW).

The qualification criterion establishes conditions that must be met at the time of receipt of Technical Proposals by the Contracting Officer in order for a proposal to be considered any further for award. The following Mandatory Qualification Criteria for this RFP is as follows:

1. Facility Mandatory Qualification

a. A minimum of 6,000 square feet of chemical storage space containing:

i. 5,000 Cubic feet of refrigeration space (+5 deg C)

ii. 10,000 Cubic feet of freezer space (-20 deg C)

iii. 500 Cubic feet of ultra-low temperature space (-80 deg C)

b. Sufficient non-recirculating Air conditioning and heating to provide controlled room temperature (+20 deg C) chemical storage space. The turnover of room air shall comply accepted industry standards and OSHA regulations.

2. Present all required current federal, state, and local approvals, licenses, certificates, permits and other legal requirements necessary for an operational facility or facilities and its contents. All required, at the proposed location and for the proposed use and occupancy have been issued.

3. If facility is not contractor owned, commitment for a non-revocable building lease through the end of the contract term.

JUSTIFICATION FOR PARAGRAPH (2): Since many of the compounds handled under this contract are of a hazardous nature, the contractor must have the licenses required by the federal, state, and local governments to receive, inventory, store, ship and dispose of such compounds.

JUSTIFICATION FOR PARAGRAPH (3): Many of the samples housed in the facility will be of a hazardous and perishable nature requiring special storage (e.g., refrigeration, dark) and handling conditions. In order to maintain sample integrity and continuous execution of tasks it is necessary that a proper and adequate facility for storage is continuously available for the term of the contract.

The base IDIQ contract is anticipated to have a period of performance and ordering period of approximately five (5) years. Awards are anticipated on or about February 15, 2023, to Offerors capable of performing all aspects of the work described in the Draft SOW attached to this notice. Task Orders placed within the ordering period of the resultant base IDIQ may extend up to five years beyond the end date of the base IDIQ contract’s period of performance/ordering period. We anticipate task orders issued against the IDIQ contract will be cost reimbursement type and/or firm fixed price. While the base IDIQ contract will not have options, options may be included at the individual task order level.

This advertisement does not commit the United States Federal Government to award any contract.

The NAICS code for this acquisition is 541990, All Other Professional, Scientific, and Technical Services with a size standard of $16.5 million dollars is being considered. THIS ACQUISITION

IS UNRESTRICTED (NOT A SET-ASIDE FOR SMALL BUSINESSES).

The Request for Proposal (RFP) NCI-DCTD-23-0001 is scheduled for electronic release on or about May 02, 2022, and receipt of proposals will be due at 4:00PM ET on or about June 13, 2022. The RFP will only be available electronically and must be accessed through the SAM.gov website at https://sam/gov/. All information required for submission of a proposal will be contained in the electronic Request for Proposal (RFP) package. No collect calls will be accepted. No facsimile transmissions will be accepted. It is the offeror’s responsibility to monitor the above-mentioned sites for release of the solicitation and any amendments. All https://sam/gov/ responsible sources may submit a proposal, which shall be considered by the agency.

POTENTIAL OFFERORS WILL BE RESPONSIBLE FOR DOWNLOADING THEIR OWN COPY

OF THE SOLICITATION AND ANY AMENDMENTS THAT MAY BE ISSUED. FAILURE TO DO

SO WILL BE AT THE FIRM’S OWN RISK. ALL INQUIRIES SHALL BE SUBMITTED

ELECTRONICALLY TO THE CONTRACTING OFFICER LISTED AS THE POINT OF

CONTACT HEREIN.

Primary Point of contact: Christy Hunter, Contracting Officer via email at christy.hunter@nih.gov Secondary Point of contact: Andrew May, Contracting Officer via email at Andrew.may@nih.gov mailto:christy.hunter@nih.gov mailto:Andrew.may@nih.gov